Friends of the Court

Madeline Moe et al. v. Dave Yost et al.

May 29, 2025

"On April 24, 2024, H.B. 68 (“the Ban”) took effect in Ohio, banning healthcare providers from providing patients under 18 with critical, medically necessary, evidence-based treatments for gender dysphoria. H.B. 68, 135th Legis. (2024). The Ban makes the provision of such treatments “unprofessional conduct,” excludes coverage for such treatments under the Ohio Medicaid program, and subjects healthcare providers to professional discipline. Ohio Rev. Code Ann. § 3129.02–06. Denying such evidence-based medical care to adolescents who meet the requisite criteria puts them at risk of significant harm. An Ohio Court of Appeals held that the Ban is unconstitutional, but Appellants ask this Court to overturn this decision. Below, amici provide the Court with an accurate description of the treatment guidelines and summarize the scientific evidence supporting the gender-affirming medical care for adolescents prohibited by the Ban."

arrow Read the Brief

Last Updated:

Policy Communications

Take Action

Make Your Voice Heard

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.